HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB: HSTC), an integrated biotechnology health and wellness company, today announced an initiative that has been started by EBITDA Capital, LLC on behalf of HST Global, Inc. for the placement of health and wellness center operations within the Native American Community.
HST Global, Inc. has requested that EBITDA Capital initiate negotiations with known contacts within the Native American community for the purpose of placing health and wellness centers on tribal reservations.
Mr. Chet Noblett, Managing General Partner, is assisting with this initiative and has a strategic plan in process. Mr. Noblett says, “We are currently working with several Native American nations and they have been very receptive to the HST Global proposals. Native Americans have always believed in the concept of being healers.”
HST is reaching across the globe to insure that its treatments and solutions are available to all communities. The Native American communities are positioned in locations that make these clinics accessible to both Native and Non-Native American people.
Mr. David Martinez has set in motion the initial phase and stated, “Native Americans wish to be in a position to partner with HST Global to offer an alternative health and wellness solution. By placing these clinics on tribal lands, the opportunity for an immediate influence is enhanced for both the Native Americans and the community at large.
Ron Howell, President and CEO of HST Global, Inc. stated, “HSTC is excited to have the opportunity to leverage the contacts EBITDA Capital has within the Native American communities in developing relationships for the opening of our health and wellness centers. The opening of clinics on tribal reservations is part of the natural progression of our strategic plan to have health and wellness clinics worldwide that offer homeopathic and alternative health care options for those who are experiencing life-threatening illnesses.”
About HST Global, Inc.
HST Global, Inc. is an Integrated Biotechnology Health and Wellness company that is developing and or acquiring a network of Wellness Centers worldwide that are primarily focused on the homeopathic and alternative treatment of late stage cancer. In addition, the company intends to acquire innovative products for the treatment of late stage cancer. In this regard, the company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer.